Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Telix Pharmaceuticals Limited Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete December 19, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX TLX Telix to Add FAP-Targeting Candidates to Theranostic Pipeline November 18, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX TLX Telix ADSs Commence Trading on Nasdaq November 13, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX TLX Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology November 13, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX TLX Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals November 03, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix® October 30, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent October 23, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals October 22, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Files Form 20-F Registration Statement for Nasdaq ADS October 17, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M October 17, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX First Patient Dosed in Phase II ‘CA-NINE’ Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery October 03, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform September 22, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix® September 17, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX CAH ‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology September 10, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances September 03, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Submits NDA for TLX101-CDx (Pixclara™) Brain Cancer Imaging Agent August 27, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Announces Reorganisation to Deliver on Strategic Priorities August 26, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities August 22, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Expanded Access Program Opens in the U.S. for TLX101-CDx, Telix’s Investigational Glioma (Brain Cancer) Imaging Agent July 29, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent July 23, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Q2 2024 Revenue and Business Highlights, Guidance Upgrade July 17, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals July 10, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Announces Launch of Proposed Initial Public Offering in the United States June 05, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging June 02, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer May 30, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Submits NDA for New Prostate Cancer Imaging Agent May 28, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer May 20, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Telix Files Registration Statement for Proposed Initial Public Offering in the United States May 17, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Q1 2024 Revenue and Business Update April 17, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation April 15, 2024 From Telix Pharmaceuticals Limited Via GlobeNewswire Tickers ASX:TLX Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
